Thursday, October 1, 2009

Is Bing a Better Place to Browse iPhone Apps?

Is Bing a Better Place to Browse iPhone Apps?: "

bing iphone appsWe’re quite impressed with Bing’s brand new Visual Search product. Launched yesterday, the it provides a pictorial way to search via image galleries.


Visual Search is the perfect solution if you’re trying to find info on an NFL quarterback but can’t remember his name, or if you need a quick refresher of Billboard number ones for the past few decades. And since it’s built using Microsoft Silverlight technology, the search process flows seamlessly and provides a visually entertaining experiment.


After careful inspection, you’ll also notice that one of Bing’s image galleries exists to make it easier for you to search and find iPhone apps. Yes, Microsoft has developed an arguably better interface for finding and exploring applications for their competitor’s device.



bing top iphone apps


Listed towards the bottom of the main page, “Top iPhone apps,” includes 500 iPhone apps that you can sort by popularity, price, release date, or name. You can also filter to view applications in these categories: top 10 free, top 10 paid, newest, most expensive, games, entertainment, and social networking.


There’s even a way to narrow apps by their store category, price range, or publisher, with options for adding and removing multiple criteria to your visual search. You can also use the scrolling bar on the right to visually breeze though thumbnail app images. Mousing over any of the images in the gallery will highlight an individual app’s metadeta, displaying its category, price, rank, and release date immediately under the search box.


We never thought we’d say this, but Microsoft has built one truly impressive way to browse iPhone apps. Though not perfect — iTunes links would be desirable — Apple could certainly stand to learn a few things from the multi-criteria search functions.


Monday, September 21, 2009

wtf!?? by sylwia presley


PopJam - Sylwia Presley

Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why.

Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why.
Extract:
From 2001 to 2006, the percentage of new products cut from development after Phase II clinical trials, when drugs are first tested against placebo, rose by 20 percent. The failure rate in more extensive Phase III trials increased by 11 percent, mainly due to surprisingly poor showings against placebo. Despite historic levels of industry investment in R&D, the US Food and Drug Administration approved only 19 first-of-their-kind remedies in 2007—the fewest since 1983—and just 24 in 2008. Half of all drugs that fail in late-stage trials drop out of the pipeline due to their inability to beat sugar pills.

The upshot is fewer new medicines available to ailing patients and more financial woes for the beleaguered pharmaceutical industry. Last November, a new type of gene therapy for Parkinson's disease, championed by the Michael J. Fox Foundation, was abruptly withdrawn from Phase II trials after unexpectedly tanking against placebo. A stem-cell startup called Osiris Therapeutics got a drubbing on Wall Street in March, when it suspended trials of its pill for Crohn's disease, an intestinal ailment, citing an "unusually high" response to placebo. Two days later, Eli Lilly broke off testing of a much-touted new drug for schizophrenia when volunteers showed double the expected level of placebo response.

It's not only trials of new drugs that are crossing the futility boundary. Some products that have been on the market for decades, like Prozac, are faltering in more recent follow-up tests. In many cases, these are the compounds that, in the late '90s, made Big Pharma more profitable than Big Oil. But if these same drugs were vetted now, the FDA might not approve some of them. Two comprehensive analyses of antidepressant trials have uncovered a dramatic increase in placebo response since the 1980s. One estimated that the so-called effect size (a measure of statistical significance) in placebo groups had nearly doubled over that time.

It's not that the old meds are getting weaker, drug developers say. It's as if the placebo effect is somehow getting stronger.

Brainshark Takes on Slideshare

Brainshark Launches Free Service: Takes on Slideshare: "

mybrainshark_logo_sep09.pngFor the last 10 years, Brainshark has offered a very popular on-demand presentations service for enterprises. While most web services today typically start out by offering free services and then slowly move towards offering paid features, Brainshark is turning this model on its head. While the company already offers a profitable paid product, Brainshark just launched a free version of its service today. MyBrainshark, as this new service is called, was built on top of Brainshark's enterprise product. In terms of its features, MyBrainshark clearly takes on Slideshare and similar services head-on, though the company is mostly targeting business customers for now. While Slideshare also allows its users to upload audio, Brainshark makes this exceptionally easy, as users can actually record their talks right from their phones. MyBrainshark supports PowerPoint, Word, Excel, and PDF documents, as well as most popular video and image formats. These documents can be up to 100MB in size. Once you have uploaded a documents, you can either add audio tracks by uploading additional MP3 files or you can call Brainshark and record the presentation over the phone.mybrainshark_landingpage.jpg


Saturday, September 19, 2009

My sort of unconference

The BIL:PIL 2009 Healthcare Innovation Conference will bring together over 200 entrepreneurs, health professionals, technologists, and laypeople to describe the future of healthcare
BIL = Benevolence. Inspiration. Levity

A classic Must view!

Monday, September 14, 2009

Pilots Use Checklists. Doctors Don't. Why Not? Must read!

by Maggie Mahar
summarising Atul Gawande's New Yorker piece The Checklist
"If a new drug were as effective at saving lives as Peter Pronovost’s checklist, there would be a nationwide marketing campaign urging doctors to use it."


The Melding of Man, Machine, and Media

by Dan Boscov-Ellen
"augmented reality... has the potential to revolutionize the way we consume media and information, particularly on mobile devices."

Digital tools let doctors see patients via Internet -- baltimoresun.com

Digital tools let doctors see patients via Internet -- baltimoresun.com

Posted using ShareThis

Health care consumers views on Health IT

Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
Consumer Engagement in Developing Electronic Health Information Systems
Final report. Based on 20 focus groups regionally and socially mixed with 4 in Spanish
extract:
"Results of the focus groups suggest that participants were optimistic that health IT would benefit health care quality. They thought that computers may add efficiency to health care and reduce medical errors, such as those associated with illegible handwriting. However, some participants were concerned that health IT might make providers more impersonal, devoting more attention to the computer screen and less to the patient.
A large proportion of the participants initially thought that health care consumers should not help in determining how health IT was designed and used. They stated that health IT was the domain of experts in medicine and computers. They felt that health care consumers like themselves lacked the knowledge needed to have a role in health IT matters. However, upon further discussion, the participants tended to feel that they needed to have a say about health IT in order to protect the privacy and security of their medical information."
 
Real Time Web Analytics